Document is current
Any future updates will be listed below
-
Authors
Ma, Jun
Xie, Ronald
Ayyadhury, Shamini https://orcid.org/0000-0002-8717-637X
Ge, Cheng
Gupta, Anubha
Gupta, Ritu
Gu, Song https://orcid.org/0000-0001-9716-5052
Zhang, Yao https://orcid.org/0000-0002-8759-4811
Lee, Gihun https://orcid.org/0009-0004-2684-2350
Kim, Joonkee https://orcid.org/0000-0002-2155-6556
Lou, Wei
Li, Haofeng https://orcid.org/0000-0001-9120-9843
Upschulte, Eric
Dickscheid, Timo
de Almeida, José Guilherme
Wang, Yixin
Han, Lin
Yang, Xin
Labagnara, Marco https://orcid.org/0009-0000-4422-2615
Gligorovski, Vojislav https://orcid.org/0000-0002-1804-8913
Scheder, Maxime
Rahi, Sahand Jamal https://orcid.org/0000-0001-6442-7087
Kempster, Carly https://orcid.org/0000-0001-5721-1050
Pollitt, Alice https://orcid.org/0000-0001-8706-5154
Espinosa, Leon
Mignot, Tâm https://orcid.org/0000-0003-4338-9063
Middeke, Jan Moritz
Eckardt, Jan-Niklas
Li, Wangkai
Li, Zhaoyang
Cai, Xiaochen
Bai, Bizhe
Greenwald, Noah F. https://orcid.org/0000-0002-7836-4379
Van Valen, David https://orcid.org/0000-0001-7534-7621
Weisbart, Erin https://orcid.org/0000-0002-6437-2458
Cimini, Beth A. https://orcid.org/0000-0001-9640-9318
Cheung, Trevor https://orcid.org/0009-0007-4903-7516
Brück, Oscar https://orcid.org/0000-0002-7842-9419
Bader, Gary D. https://orcid.org/0000-0003-0185-8861
-
Funding
Funding for this research was provided by:
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (NSERC, RGPIN-2020-06189 and DGECR-2020-00294)
- License Information
-
More Information
Article History
Received: 27 July 2023
Accepted: 4 March 2024
First Online: 26 March 2024
Competing interests
: S.G. is employed by Nanjing Anke Medical Technology Co. J.M.M. and J.-N.E. are co-owners of Cancilico. D.V.V. is a co-founder and chief scientist of Barrier Biosciences and holds equity in the company. O.B. declares the following competing financial interests: consultancy fees from Novartis, Sanofi and Amgen, outside the submitted work; research grants from Pfizer and Gilead Sciences, outside the submitted work; and stock ownership (Hematoscope) outside the submitted work. All other authors declare no competing interests.
